The flu vaccine is its first using mRNA technology for influenza.
2026-02-12 929词 中等
Moderna posted on its website a timeline of its communications with the FDA, in which the agency asked for additional information comparing how Moderna’s flu shot stacked up against existing ones for older people, who are more vulnerable to flu complications. The company says it started a Phase 3 study in 2025 involving more than 40,000 people over age 50—some of whom took mRNA 1010.6, and others who took the flu shot Fluarix.
免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。